A serial technology and healthcare entrepreneur, Ammad Khan is committed to understanding global healthcare challenges and innovating their boldest solutions.

Today, Ammad is the Founder and CEO of RadiusXR, an industry-first, digital health platform that has revolutionized visual diagnostics. RadiusXR streamlines the diagnostic process, enhances patient experience, reduces staff workload, and addresses the growing demands on caregivers worldwide — a winning solution for patients and providers alike. RadiusXR has been recognized with numerous accolades, including the 2023 CES Innovation award in Digital Health and AR/VR Technology, Innovation Tri-Valley Game Changer award, and Fast Company’s Most Innovative Companies 2024 award. Ammad is also featured by Forbes in The Next 1000, and by the New York Times for their Fast Forward Series, Technology that Bridges the Gap to Better Sight.

After completing his undergraduate studies, a stint in the biotech industry honed Ammad’s skills in business strategy, leadership, regulatory compliance, and global collaboration. Ammad was next Founder and CEO of CitrusBits, renowned for crafting high-performing, award-winning mobile and digital technology, and partner to global brands such as Mercedes-Benz, Burger King, Symantec, Sotheby’s, and many others.

Ammad recognized early on the potential of virtual reality technology to deliver precise, portable, diagnostic vision care. In 2016, he launched IrisVision — featuring lifestyle-friendly, digital eye health solutions to help challenged patients preserve their sight. Ammad’s leadership rallied diverse stakeholders from academics and physicians to investors and partners — securing private fundings well as multiple grants from the National Institutes of Health (NIH). IrisVision has earned widespread acclaim, including recognition in top peer-reviewed scientific journals and accolades such as the 2019 CES Innovation Award.

Through his visionary leadership, Ammad is building successful, purpose-driven companies rooted in compassion, innovation, and a commitment to democratizing healthcare outcomes on a global scale.